51 – 60 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
(
- Contribution to journal › Article
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
(
- Contribution to journal › Article
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
-
Mark
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
(
- Contribution to journal › Article
-
Mark
Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
(
- Contribution to journal › Article
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article
-
Mark
Plant foods and estrogen receptor {alpha} and {beta} defined breast cancer: observations from the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein in Alzheimer's disease: Binding to Abeta(1-42) and to dead cells.
(
- Contribution to journal › Article